Cyclic Nucleotide-induced Maturation of Human Promyelocytic Leukemia Cells
AUTOR(ES)
Chaplinski, Thomas J.
RESUMO
Myeloid differentiation in vitro is characterized by the sequential appearance of morphological, functional, and biochemical markers of maturation. We examined the effect of agents that increased the intracellular concentration of adenosine 3′5′-cyclic monophosphate on the expression of these markers by human promyelocytic leukemia cells (HL60). Cells treated with 500 μM N6,O2-dibutyryl adenosine 3′5′-cyclic monophosphate expressed formyl peptide and complement receptors, reduced nitroblue tetrazolium, adhered to substrate, demonstrated chemotaxis and stimulated lysosomal enzyme release, rapidly ceased proliferation, and assumed the morphology of myelocytes and metamyelocytes. Prostaglandin E2 (100 nM) and theophyllin (500 μM) induced similar functional changes but the cells did not mature beyond the myelocyte stage. Cholera toxin (1 or 50 nM) induced formyl-peptide receptor expression and adherence, but the cells did not reduce nitroblue tetrazolium, continued to proliferate, and were unchanged morphologically. Formyl-peptide receptor expression was the earliest marker of these modified programs of maturation. The receptor appeared within 2 h after treatment and increased linearly for 72 h. Receptor expression was dependent on new protein synthesis. At 48 h, Scatchard analysis demonstrated 2.4 × 105 receptors/ cell with a KD of 1.3 nM.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=370308Documentos Relacionados
- Temperature- and cyclic nucleotide-induced phase transitions of Histoplasma capsulatum.
- Nucleotide-induced conformations in the neck region of dimeric kinesin
- Possible mechanism of phorbol diester-induced maturation of human promyelocytic leukemia cells.
- Structure of rat BCKD kinase: Nucleotide-induced domain communication in a mitochondrial protein kinase
- Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.